| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000268812.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010783191 |
Resistant |
| ENSG00000268812.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.027070613 |
Sensitive |
| ENSG00000268812.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.00318248 |
Sensitive |
